Pediatric Veins Cannulation Technique

NCT ID: NCT02918604

Last Updated: 2016-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

multicenter, prospective and cohort study to evaluate infrared technology for identifying and and indwelling peripheral veins in 0 up to 4 years old children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

AIM OF THE STUDY The primary objective of this study is to determine the success rate at first attempt of peripheral veins cannulation in small children (\<5yrs) and infants (\<1yr) of Veinsite compared with traditional palpation method performed by skilled operators.

The secondary objective of this study is to determine the time to cannulation using the two techniques, the difference in visualized veins using the Veinsite or the direct visualization and palpation of the patients' skin, cannula indwelling time and complications related to the procedure.

DESIGN Prospective randomized controlled study

Population

It is expected to recruit 60 pediatric patients undergoing peripheral vein cannulation with known difficulties according the difficult venous access score (DIVA) (6) in the following centers:

1. Fondazione IRCCS Istituto Neurologico "C.Besta" , Milano
2. Ospedale Pediatrico Bambino Gesù, IRCCS, Roma

Duration of study Patient will be followed from the day of peripheral vein cannulation till the peripheral cannula will be removed (max 3 days) in order to assess any cause of venous extravasation. The recruitment phase is supposed to be 6 months after achieving the ethical-administrative authorization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Successful Vein Cannulation at First Attempt

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

B : veinsite access

infrared technology vein access

Group Type OTHER

infrared technology: Veinsite

Intervention Type DEVICE

peripheral vein access performed with Veinsite support by expert paediatric anaesthesiologists and intensivists

A: control group

conventional vein access

Group Type ACTIVE_COMPARATOR

infrared technology: Veinsite

Intervention Type DEVICE

peripheral vein access performed with Veinsite support by expert paediatric anaesthesiologists and intensivists

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

infrared technology: Veinsite

peripheral vein access performed with Veinsite support by expert paediatric anaesthesiologists and intensivists

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and Female children from 1 month to 5 years Of age
* American Society of Anesthesiologists Classification (ASA) I: without systemic disease
* American Society of Anesthesiologists Classification (ASA) II: moderate systemic disease
* American Society of Anesthesiologists Classification (ASA) III: severe systemic disease that limits normal activity, without invalidity.
* Scheduled for any indication of peripheral venous line placement
* Admission to an Intensive Care Unit, Neurosurgery ward or pediatric ward of one of the hospitals included
* Children whose parents (or legal tutors) have given their informed written consent

Exclusion Criteria

* Any contraindication for peripheral line placement
* Children whose parents (or legal tutors) denied their own consensus
Maximum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bambino Gesù Hospital and Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emanuele Rossetti

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Reigart JR, Chamberlain KH, Eldridge D, O'Brien ES, Freeland KD, Larsen P, Goff D, Hartzog TH. Peripheral intravenous access in pediatric inpatients. Clin Pediatr (Phila). 2012 May;51(5):468-72. doi: 10.1177/0009922811435164. Epub 2012 Jan 20.

Reference Type BACKGROUND
PMID: 22267855 (View on PubMed)

Chapman LL, Sullivan B, Pacheco AL, Draleau CP, Becker BM. VeinViewer-assisted Intravenous catheter placement in a pediatric emergency department. Acad Emerg Med. 2011 Sep;18(9):966-71. doi: 10.1111/j.1553-2712.2011.01155.x. Epub 2011 Aug 19.

Reference Type BACKGROUND
PMID: 21854488 (View on PubMed)

Kim MJ, Park JM, Rhee N, Je SM, Hong SH, Lee YM, Chung SP, Kim SH. Efficacy of VeinViewer in pediatric peripheral intravenous access: a randomized controlled trial. Eur J Pediatr. 2012 Jul;171(7):1121-5. doi: 10.1007/s00431-012-1713-9. Epub 2012 Mar 14.

Reference Type BACKGROUND
PMID: 22415409 (View on PubMed)

Yen K, Riegert A, Gorelick MH. Derivation of the DIVA score: a clinical prediction rule for the identification of children with difficult intravenous access. Pediatr Emerg Care. 2008 Mar;24(3):143-7. doi: 10.1097/PEC.0b013e3181666f32.

Reference Type BACKGROUND
PMID: 18347490 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AR-INNCB 11-2013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Venous Occlusion and Limb Swelling
NCT02241343 TERMINATED NA